Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Andrew Blann

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Platelet Activation

Procedures

Disorders

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
138
Lip, Gregory
35
Lip, G Y H
22
Beevers, Gareth
19
McCollum, Charles
19
Nadar, Sunil
15
Bareford, David
15
Belgore, Funmi
13
Caine, Graham
12
Chong, Aun Yeong
12
Seigneur, Martine
11
Stonelake, Paul
11
Felmeden, Dirk
10
Conri, Claude
10
Constans, Joël
10
Li-Saw-Hee, Foo Leong

Sign-in to see all Coauthors

Publications

TOP 3
Goon Patrick K Y; Lip Gregory Y H; Stonelake Paul S; Blann Andrew D
Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Hamaad Ali; Sosin Michael D; Blann Andrew D; Lip Gregory Y H; MacFadyen Robert J
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.
Foster Will; Shantsila Eduard; Carruthers David; Lip Gregory Y H; Blann Andrew D
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Andrew Blann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Goon Patrick K Y; Lip Gregory Y H; Stonelake Paul S; Blann Andrew D
Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Neoplasia (New York, N.Y.) 2009;11(8):771-9.
2009: Hamaad Ali; Sosin Michael D; Blann Andrew D; Lip Gregory Y H; MacFadyen Robert J
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.
Clinical cardiology 2009;32(4):204-9.
2009: Foster Will; Shantsila Eduard; Carruthers David; Lip Gregory Y H; Blann Andrew D
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.
Rheumatology (Oxford, England) 2009;48(3):285-8.
2009: Arunkalaivanan A S; Morrison A; Jha S; Blann A
Prevalence of urinary and faecal incontinence among female members of the Hypermobility Syndrome Association (HMSA).
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2009;29(2):126-8.
2009: Foster Will; Carruthers David; Lip Gregory Y H; Blann Andrew D
Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology.
Thrombosis research 2009;123(4):659-64.
2009: Blann Andrew D; Khoo Chee W
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.
Vascular health and risk management 2009;5():693-704.
2009: Blann A D; Nation B R
Good analytical practice: statistics and handling data in biomedical science: A primer and directions for authors. Part 2: analysis of data from three or more groups, and instructions for authors.
British journal of biomedical science 2009;66(1):42-6.
2008: Boos C J; Balakrishnan B; Blann A D; Lip G Y H
The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.
Journal of thrombosis and haemostasis : JTH 2008;6(11):1841-50.
2008: Idriss Naglaa K; Blann Andrew D; Lip Gregory Y H
Hemoxygenase-1 in cardiovascular disease.
Journal of the American College of Cardiology 2008;52(12):971-8.
2008: Lip Gregory Y H; Blann Andrew D
Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state?
Hypertension 2008;52(2):218-9.
2008: Shantsila E; Blann A D; Lip G Y H
Circulating endothelial cells: from bench to clinical practice.
Journal of thrombosis and haemostasis : JTH 2008;6(5):865-8.
2008: Blann A D; Mohan J S; Bareford D; Lip G Y H
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.
Journal of thrombosis and thrombolysis 2008;25(2):185-9.
2008: Blann A D; Nation B R
Good analytical practice: statistics and handling data in biomedical science. A primer and directions for authors. Part 1: Introduction. Data within and between one or two sets of individuals.
British journal of biomedical science 2008;65(4):209-17.
2007: Caine Graham J; Lip Gregory; Zanetto Ulyses; Maheshwari Mahwandra; Stonelake Paul S; Blann Andrew D
A comparison of plasma versus histologic indices of angiogenic markers in breast cancer.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(4):382-8.
2007: Boos Christopher J; Balakrishnan Balu; Jessani Shahirose; Blann Andrew D; Lip Gregory Y H
Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.
Chest 2007;132(6):1920-6.
2007: Jaumdally Rumi J; Varma Chetan; Blann Andrew D; MacFadyen Robert J; Lip Gregory Y H
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.
Chest 2007;132(5):1532-9.
2007: Freestone Bethan; Chong Aun Yeong; Nuttall Sarah; Blann Andrew D; Lip Gregory Y H
Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
Chest 2007;132(4):1253-8.
2007: Blann Andrew D
Platelets: the universal killer?
Biochimica et biophysica acta 2007;1772(7):715-7.
2007: Spencer Charles G C; Felmeden Dirk C; Blann Andrew D; Lip Gregory Y H
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
American journal of hypertension 2007;20(6):699-704.
2007: Caine Graham J; Ryan Peter; Lip Gregory Y H; Blann Andrew D
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
Cancer letters 2007;251(2):296-301.
2007: Choudhury Anirban; Chung Irene; Blann Andrew D; Lip Gregory Y H
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Journal of the American College of Cardiology 2007;49(19):1957-64.
2007: Varughese G I; Patel J V; Tomson J; Blann A D; Hughes E A; Lip G Y H
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Journal of internal medicine 2007;261(4):384-91.
2007: Caine Graham J; Stonelake Paul S; Lip Gregory Y H; Blann Andrew D
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Cancer letters 2007;248(1):131-6.
2007: Choudhury Anirban; Chung Irene; Blann Andrew D; Lip Gregory Y H
Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Chest 2007;131(3):809-15.
2007: Dignat-George Françoise; Sabatier Florence; Blann Andrew; Woywodt Alexander
Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):e1-2; author reply e3-5.
2007: Spencer C G C; Felmeden D C; Blann A D; Lip G Y H
Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Journal of internal medicine 2007;261(1):82-90.
2007: Ceconi Claudio; Fox Kim M; Remme William J; Simoons Marteen L; Bertrand Michael; Parrinello Giovanni; Kluft Cornelius; Blann Andrew; Cokkinos Dennis; Ferrari Roberto;
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
Cardiovascular research 2007;73(1):237-46.
2007: Boos Christopher J; Blann Andrew D; Lip Gregory Y H
Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells.
Methods in molecular medicine 2007;139():211-24.
2007: Jaumdally Rumi J; Varma Chetan; Blann Andrew D; Macfadyen Robert J; Lip Gregory Y H
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels.
Annals of medicine 2007;39(8):628-33.
2007: Blann A D
Diagnosis, treatment and management of venous thromboembolism: recent developments relevant to biomedical scientists.
British journal of biomedical science 2007;64(3):136-41.
2007: Blann A D; Marwah S S; Cobley A J; Bareford D
Increased levels of soluble P-selectin correlate with iron overload in sickle cell disease.
British journal of biomedical science 2007;64(3):124-6.
2007: Jaumdally Rumi J; Varma Chetan; Blann Andrew D; MacFadyen Robert J; Lip Gregory Y H
Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
Annals of medicine 2007;39(4):298-305.
2007: Choudhury Anirban; Chung Irene; Blann Andrew; Lip Gregory Y H
Platelet adhesion in atrial fibrillation.
Thrombosis research 2007;120(4):623-9.
2006: Lee K W; Blann A D; Jolly K; Lip G Y H;
Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study.
Heart (British Cardiac Society) 2006;92(12):1732-8.
2006: Boos Christopher J; Lip Gregory Y H; Blann Andrew D
Circulating endothelial cells in cardiovascular disease.
Journal of the American College of Cardiology 2006;48(8):1538-47.
2006: Boos Christopher J; Lane Deirdre A; Kang Delene; Goon Patrick K Y; Blann Andrew D; Lip Gregory Y H
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood.
Journal of thrombosis and thrombolysis 2006;22(2):125-31.
2006: Nadar Sunil; Blann Andrew D; Lip Gregory Y H
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
American journal of hypertension 2006;19(9):970-7; discussion 978.
2006: Blann Andrew D; Pretorius Adolf
Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?
Atherosclerosis 2006;188(1):12-8.
2006: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
International journal of cardiology 2006;111(2):302-8.
2006: Goon Patrick K Y; Boos Christopher J; Stonelake Paul S; Blann Andrew D; Lip Gregory Y H
Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.
Thrombosis and haemostasis 2006;96(1):45-52.
2006: Chong Aun Yeong; Freestone Bethan; Patel Jeetesh; Lim Hoong Sern; Hughes Elizabeth; Blann Andrew D; Lip Gregory Y H
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
The American journal of cardiology 2006;97(5):671-5.
2006: Chong Aun Yeong; Lip Gregory Y H; Freestone Bethan; Blann Andrew D
Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(2):167-72.
2006: Goon P K Y; Lip G Y H; Boos C J; Stonelake P S; Blann A D
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.
Neoplasia (New York, N.Y.) 2006;8(2):79-88.
2006: Blann Andrew; Cain Graham; Bareford David
Vascular endothelial growth factor and platelets in primary (essential) thrombocythaemia.
British journal of haematology 2006;132(4):530-1.
2006: Bacon Simon L; Ring Christopher; Hee Foo Li Saw; Lip Gregory Y H; Blann Andrew D; Lavoie Kim L; Carroll Douglas
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients.
Biological psychology 2006;71(2):162-70.
2006: Blann Andrew D
Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years.
Thrombosis and haemostasis 2006;95(1):49-55.
2006: Blann Andrew D; Lip Gregory Y H
Venous thromboembolism.
BMJ (Clinical research ed.) 2006;332(7535):215-9.
2006: Freestone Bethan; Chong Aun Yeong; Blann Andrew D; Lip Gregory Y H
The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
Thrombosis research 2006;118(4):479-85.
2006: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction.
Thrombosis research 2006;118(3):305-12.
2006: Mohan J S; Lip G Y H; Bareford D; Blann A D
Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Thrombosis research 2006;117(6):623-9.
2005: Hamaad Ali; Sosin Michael; Blann Andrew D; Patel Jeetesh; Lip Gregory Y H; MacFadyen Robert J
Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability.
Clinical cardiology 2005;28(12):570-6.
2005: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
Thrombosis and haemostasis 2005;94(5):1077-83.
2005: Nadar Sunil K; Karalis Ioannis; Al Yemeni Eman; Blann Andrew D; Lip Gregory Y H
Plasma markers of angiogenesis in pregnancy induced hypertension.
Thrombosis and haemostasis 2005;94(5):1071-6.
2005: Lee K W; Blann A D; Ingram J; Jolly K; Lip G Y H;
Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM).
Heart (British Cardiac Society) 2005;91(11):1413-7.
2005: Jilma Bernd; Cvitko Tuende; Winter-Fabry Astrid; Petroczi Karin; Quehenberger Peter; Blann Andrew D
High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men.
Thrombosis and haemostasis 2005;94(4):797-801.
2005: Nadar Sunil K; Lip Gregory Y H; Lee Kaeng W; Blann Andrew D
Circulating endothelial cells in acute ischaemic stroke.
Thrombosis and haemostasis 2005;94(4):707-12.
2005: Freestone Bethan; Lip Gregory Y H; Chong Aun Yeong; Nadar Sunil; Lee Kaeng W; Blann Andrew D
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
Thrombosis and haemostasis 2005;94(4):702-6.
2005: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation.
American heart journal 2005;150(4):756-66.
2005: Nadar S K; Blann A; Beevers D G; Lip G Y H
Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Journal of internal medicine 2005;258(4):336-43.
2005: Tan Kiat T; Tayebjee Muzahir H; Macfadyen Robert J; Lip Gregory Y H; Blann Andrew D
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
Platelets 2005;16(6):368-71.
2005: Mohan J S; Lip P L; Blann A D; Bareford D; Lip G Y H
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
The British journal of ophthalmology 2005;89(7):815-9.
2005: Lim H S; Lip G Y H; Beevers D G; Blann A D
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
European journal of clinical investigation 2005;35(5):324-9.
2005: Lim Hoong Sern; Lip Gregory Y H; Blann Andrew D
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
Atherosclerosis 2005;180(1):113-8.
2005: Lip G Y H; Foster W; Blann A D
Plasma von Willebrand factor levels and surrogates of atherosclerosis.
Journal of thrombosis and haemostasis : JTH 2005;3(4):659-61.
2005: Mohan Junette S; Lip Gregory Yh; Wright Josh; Bareford David; Blann Andrew D
Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(3):209-14.
2005: Blann Andrew D; Tan Kiat T; Tayebjee Muzahir H; Davagnanam Indran; Moss Mark; Lip Gregory Y H
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Thrombosis and haemostasis 2005;93(3):578-83.
2005: Caine G J; Harris A L; Christodoulos K; Lip G Y H; Blann A D
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Cancer letters 2005;219(2):163-7.
2005: Lim H S; Chong A Y; Freestone B; Blann A D; Lip G Y H
The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(3):249-55.
2005: Blann Andrew D; Woywodt Alexander; Bertolini Francesco; Bull Todd M; Buyon Jill P; Clancy Robert M; Haubitz Marion; Hebbel Robert P; Lip Gregory Y H; Mancuso Patrizia; Sampol Jose; Solovey Anna; Dignat-George Françoise
Circulating endothelial cells. Biomarker of vascular disease.
Thrombosis and haemostasis 2005;93(2):228-35.
2005: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
American journal of hypertension 2005;18(1):104-15.
2005: Lee Kaeng W; Lip Gregory Y H; Tayebjee Muzahir; Foster William; Blann Andrew D
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.
Blood 2005;105(2):526-32.
2005: Freestone Bethan; Chong Aun Yeong; Lim Hoong Sern; Blann Andrew; Lip Gregory Y H
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
Annals of medicine 2005;37(5):365-72.
2005: Karalis Ioannis; Nadar Sunil K; Al Yemeni Eman; Blann Andrew D; Lip Gregory Y H
Platelet activation in pregnancy-induced hypertension.
Thrombosis research 2005;116(5):377-83.
2005: Chong Aun Yeong; Chin Bernard S P; Blann Andrew D; Lip Gregory Y H
Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.
Thrombosis research 2005;116(2):181-3.
2005: Tan Kiat T; Tayebjee Muzahir H; Lynd Cheryl; Blann Andrew D; Lip Gregory Y H
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Annals of medicine 2005;37(1):61-6.
2005: Nadar Sunil K; Caine Graham J; Blann Andrew D; Lip Gregory Y H
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion.
Annals of medicine 2005;37(1):55-60.
2005: Tayebjee Muzahir H; Lip Gregory Y H; Blann Andrew D; Macfadyen Robert J
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Thrombosis research 2005;115(3):205-10.
2004: Nadar Sunil K; Lip Gregory Y H; Blann Andrew D
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project.
Thrombosis and haemostasis 2004;92(6):1342-8.
2004: Lim Hoong Sern; Blann Andrew D; Chong Aun Yeong; Freestone Bethan; Lip Gregory Y H
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
Diabetes care 2004;27(12):2918-24.
2004: Lip P L; Chatterjee S; Caine G J; Hope-Ross M; Gibson J; Blann A D; Lip G Y H
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
The British journal of ophthalmology 2004;88(12):1543-6.
2004: Blann Andrew; Caine Graham; Bareford David
Abnormal vascular, platelet and coagulation markers in primary thrombocythaemia are not reversed by treatments that reduce the platelet count.
Platelets 2004;15(7):447-9.
2004: Lim Hoong Sern; Lip Gregory Y H; Blann Andrew D
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension.
The Journal of clinical endocrinology and metabolism 2004;89(11):5377-81.
2004: Deplanque G; Madhusudan S; Jones P H; Wellmann S; Christodoulos K; Talbot D C; Ganesan T S; Blann A; Harris A L
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma.
British journal of cancer 2004;91(9):1645-50.
2004: Nadar S K; Blann A D; Lip G Y H
Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
Journal of internal medicine 2004;256(4):331-7.
2004: Lee Kaeng W; Lip Gregory Y H; Blann Andrew D
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Circulation 2004;110(16):2355-60.
2004: Chong Aun Yeong; Blann Andrew D; Patel Jeetesh; Freestone Bethan; Hughes Elizabeth; Lip Gregory Y H
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
Circulation 2004;110(13):1794-8.
2004: Tayebjee Muzahir H; Nadar Sunil; Blann Andrew D; Gareth Beevers D; MacFadyen Robert J; Lip Gregory Y H
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
American journal of hypertension 2004;17(9):764-9.
2004: Caine Graham J; Nadar Sunil K; Lip Gregory Y H; Stonelake Paul S; Blann Andrew D
Platelet adhesion in breast cancer: development and application of a novel assay.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(6):513-8.
2004: Beevers D Gareth; Lip Gregory Y H; Blann Andrew D
Salt intake and Helicobacter pylori infection.
Journal of hypertension 2004;22(8):1475-7.
2004: Blann Andrew D
Angiogenesis and platelets: the clot thickens further.
Cardiovascular research 2004;63(2):192-3.
2004: Nadar Sunil K; Blann Andrew D; Kamath Sridhar; Beevers D Gareth; Lip Gregory Y H
Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of the American College of Cardiology 2004;44(2):415-22.
2004: Caine Graham J; Lip Gregory Y H; Stonelake Paul S; Ryan Peter; Blann Andrew D
Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma.
Thrombosis and haemostasis 2004;92(1):185-90.
2004: Jones P H; Christodoulos K; Dobbs N; Thavasu P; Balkwill F; Blann A D; Caine G J; Kumar S; Kakkar A J; Gompertz N; Talbot D C; Ganesan T S; Harris A L
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
British journal of cancer 2004;91(1):30-6.
2004: Lim Hoong Sern; Blann Andrew D; Lip Gregory Y H
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Circulation 2004;109(21):2524-8.
2004: Spencer Charles G C; Martin Steven C; Felmeden Dirk C; Blann Andrew D; Beevers Gareth D; Lip Gregory Y H
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
International journal of cardiology 2004;94(2-3):293-300.
2004: Roldán Vanessa; Marín Francisco; Blann Andrew
Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(2):179-82.
2004: Makin Andrew J; Blann Andrew D; Chung Natali A Y; Silverman Stanley H; Lip Gregory Y H
Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
European heart journal 2004;25(5):371-6.
2004: Belgore F; Blann A; Neil D; Ahmed A S; Lip G Y H
Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries.
Journal of clinical pathology 2004;57(3):266-72.
2004: Chong Aun Yeong; Caine Graham J; Freestone Bethan; Blann Andrew D; Lip Gregory Y H
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Journal of the American College of Cardiology 2004;43(3):423-8.
2004: Landray Martin J; Wheeler David C; Lip Gregory Y H; Newman David J; Blann Andrew D; McGlynn Fiona J; Ball Simon; Townend John N; Baigent Colin
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(2):244-53.
2004: Spencer C G C; Gurney D; Felmeden D C; Blann A D; Beevers D G; Lip G Y H
Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of internal medicine 2004;255(1):59-67.
2004: Nadar Sunil; Blann Andrew D; Lip Gregory Y H
Antihypertensive therapy and endothelial function.
Current pharmaceutical design 2004;10(29):3607-14.
2004: Nadar Sunil; Blann Andrew D; Lip Gregory Y H
Endothelial dysfunction: methods of assessment and application to hypertension.
Current pharmaceutical design 2004;10(29):3591-605.
2004: Nadar Sunil; Blann Andrew D; Lip Gregory Y H
Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.
Annals of medicine 2004;36(7):552-7.
2004: Caine Graham J; Lip Gregory Y; Blann Andrew D
Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis.
Annals of medicine 2004;36(4):273-7.
2004: Lip Gregory Y H; Blann Andrew D
Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.
Annals of medicine 2004;36(2):119-25.
2004: Nadar Sunil K; Al Yemeni Eman; Blann Andrew D; Lip Gregory Y H
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Thrombosis research 2004;113(2):123-8.
2003: Blann Andrew D; Nadar Sunil K; Lip Gregory Y H
The adhesion molecule P-selectin and cardiovascular disease.
European heart journal 2003;24(24):2166-79.
2003: Roldán Vanessa; Marín Francisco; Lip Gregory Y H; Blann Andrew D
Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature.
Thrombosis and haemostasis 2003;90(6):1007-20.
2003: Chung N A; Lydakis C; Belgore F; Li-Saw-Hee F L; Blann A D; Lip G Y H
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.
Heart (British Cardiac Society) 2003;89(12):1411-5.
2003: Chin B S P; Blann A D; Gibbs C R; Chung N A Y; Conway D G; Lip G Y H
Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure.
European journal of clinical investigation 2003;33(11):941-8.
2003: Caine G J; Blann A D; Stonelake P S; Ryan P; Lip G Y H
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
European journal of clinical investigation 2003;33(10):883-90.
2003: Belgore F; Lip G Y H; Blann A D
Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells.
European journal of clinical investigation 2003;33(10):833-9.
2003: Chin Bernard S P; Gibbs Christopher R; Blann Andrew D; Lip Gregory Y H
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Clinical science (London, England : 1979) 2003;105(4):507-12.
2003: Dignat-George Francoise; Sampol José; Lip Gregory; Blann Andrew D
Circulating endothelial cells: realities and promises in vascular disorders.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):495-9.
2003: Blann Andrew D
How a damaged blood vessel wall contibutes to thrombosis and hypertenasion.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):445-8.
2003: Blann Andrew D
Assessment of endothelial dysfunction: focus on atherothrombotic disease.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):256-61.
2003: Constans Joel; Dupuy Remy; Blann Andrew D; Resplandy Francois; Seigneur Martine; Renard Martine; Longy-Boursier Maïte; Schaeverbeke Thierry; Guérin Viviane; Boisseau Michel R; Conri Claude
Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus.
The Journal of rheumatology 2003;30(9):1963-6.
2003: Chin Bernard S P; Conway Dwayne S G; Chung Natalie A Y; Blann Andrew D; Gibbs Christopher R; Lip Gregory Y H
Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(6):515-21.
2003: Felmeden Dirk C; Spencer Charles G C; Chung Natali A Y; Belgore Funmi M; Blann Andrew D; Beevers D Gareth; Lip Gregory Y H
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
The American journal of cardiology 2003;92(4):400-5.
2003: Roldán Vanessa; Marín Francisco; Blann Andrew D; García Amaya; Marco Pascual; Sogorb Francisco; Lip Gregory Y H
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.
European heart journal 2003;24(14):1373-80.
2003: Fijnheer Rob; Blann Andrew D
The endothelium and coagulopathy in systemic lupus erythematosus: hyperhomocysteinemia as a developing risk factor.
The Journal of rheumatology 2003;30(7):1400-2.
2003: Nadar Sunil; Blann Andrew; Lip Gregory Y H
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):513-4.
2003: Felmeden D C; Blann A D; Spencer C G C; Beevers D G; Lip G Y H
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):425-31.
2003: Tan Kiat T; Lip Gregory Y H; Blann Andrew D
Post-stroke inflammatory response: effects of stroke evolution and outcome.
Current atherosclerosis reports 2003;5(4):245-51.
2003: Blann Andrew D; Nadar Sunil; Lip Gregory Y H
Pharmacological modulation of platelet function in hypertension.
Hypertension 2003;42(1):1-7.
2003: Blann Andrew D; Lip Gregory Y H
Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(4):335-40.
2003: Tan Kiat Tsong; Blann Andrew D
To stroke or not to stroke: is ICAM-1 or CRP the answer?
Neurology 2003;60(12):1884-5.
2003: Graninger Monika; Marsik Claudia; Dukic Tanja; Wagner Oswald F; Blann Andrew D; Jilma Bernd
Enalapril does not alter adhesion molecule levels in human endotoxemia.
Shock (Augusta, Ga.) 2003;19(5):448-51.
2003: Caine Graham J; Blann Andrew D
Soluble p-selectin should be measured in citrated plasma, not in serum.
British journal of haematology 2003;121(3):530-2.
2003: Blann Andrew D; Marwah Sukhjinder; Serjeant Graham; Bareford David; Wright Josh
Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(3):255-9.
2003: Felmeden D C; Blann A D; Lip G Y H
Angiogenesis: basic pathophysiology and implications for disease.
European heart journal 2003;24(7):586-603.
2003: Chong A-Y; Blann A D; Lip G Y H
Assessment of endothelial damage and dysfunction: observations in relation to heart failure.
QJM : monthly journal of the Association of Physicians 2003;96(4):253-67.
2003: Chin Bernard S P; Langford Nigel J; Nuttall Sarah L; Gibbs Christopher R; Blann Andrew D; Lip Gregory Y H
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(2):171-4.
2003: Felmeden Dirk C; Spencer Charles G C; Blann Andrew D; Beevers D Gareth; Lip Gregory Y H
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.
Hypertension 2003;41(3):528-33.
2003: Blann A D; Constans J; Carpentier P; Renard M; Satger B; Guérin V; Boisseau M R; Neau-Cransac N; Conri C
Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease.
Thrombosis research 2003;109(4):203-6.
2003: Felmeden D C; Spencer C G C; Blann A D; Beevers D G; Lip G Y H
Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of internal medicine 2003;253(1):81-91.
2003: Blann Andrew D; Fitzmaurice David A; Lip Gregory Y H
Anticoagulation in hospitals and general practice.
BMJ (Clinical research ed.) 2003;326(7381):153-6.
2003: Caine Graham J; Blann Andrew D; Stonelake Paul S; Kehoe Sean T; Lip Gregory Y H
Tamoxifen for breast-cancer prevention.
Lancet 2003;361(9352):177-8; author reply 178.
2003: Felmeden Dirk C; Spencer Charles G C; Belgore Funmi M; Blann Andrew D; Beevers D Gareth; Lip Gregory Y H
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
American journal of hypertension 2003;16(1):11-20.
2003: Blann A D; Burrows G; McCollum C N
Oxidised and native low-density lipoproteins induce the release of von Willebrand factor from human endothelial cells in vitro.
British journal of biomedical science 2003;60(3):155-60.
2002: Chin Bernard S P; Chung Natali A Y; Gibbs Christopher R; Blann Andrew D; Lip Gregory Y H
Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure.
The American journal of cardiology 2002;90(11):1258-60.
2002: Kamath S; Blann A D; Chin B S P; Lanza F; Aleil B; Cazenave J P; Lip G Y H
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
European heart journal 2002;23(22):1788-95.
2002: Lip P L; Felmeden D C; Blann A D; Matheou N; Thakur S; Cunliffe I A; Lip G Y H
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.
The British journal of ophthalmology 2002;86(11):1299-302.
2002: Blann A D; Williams N R; Lip G Y H; Rajput-Williams J; Howard A N
Acute ingestion of red wine by men activates platelets but does not influence endothelial markers: no effect of white wine.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(7):647-51.
2002: Fitzmaurice David A; Blann Andrew D; Lip Gregory Y H
Bleeding risks of antithrombotic therapy.
BMJ (Clinical research ed.) 2002;325(7368):828-31.
2002: Blann Andrew D; Landray Martin J; Lip Gregory Y H
ABC of antithrombotic therapy: An overview of antithrombotic therapy.
BMJ (Clinical research ed.) 2002;325(7367):762-5.
2002: Chung N A Y; Lydakis C; Belgore F; Blann A D; Lip G Y H
Angiogenesis in myocardial infarction. An acute or chronic process?
European heart journal 2002;23(20):1604-8.
2002: Chung Natali A Y; Belgore Funmi; Li-Saw-Hee Foo Leong; Conway Dwayne S G; Blann Andrew D; Lip Gregory Y H
Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?
Stroke; a journal of cerebral circulation 2002;33(9):2187-91.
2002: Blann Andrew D; Ridker Paul M; Lip Gregory Y H
Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?
Stroke; a journal of cerebral circulation 2002;33(9):2141-3.
2002: Blann A D; McCollum C N; Lip G Y
Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(6):513-8.
2002: Kamath Sridhar; Blann Andrew D; Chin Bernard S P; Lip Gregory Y H
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Journal of the American College of Cardiology 2002;40(3):484-90.
2002: Spencer Charles G C; Gurney David; Blann Andrew D; Beevers D Gareth; Lip Gregory Y H;
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Hypertension 2002;40(1):61-6.
2002: Gurney David; Lip Gregory Y H; Blann Andrew D
A reliable plasma marker of platelet activation: does it exist?
American journal of hematology 2002;70(2):139-44.
2002: Lip G Y H; Blann A D; Farooqi I S; Zarifis J; Sagar G; Beevers D G
Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(4):339-47.
2002: Lip G Y H; Edmunds E; Nuttall S L; Landray M J; Blann A D; Beevers D G
Oxidative stress in malignant and non-malignant phase hypertension.
Journal of human hypertension 2002;16(5):333-6.
2002: Kamath Sridhar; Blann Andrew D; Caine Graham J; Gurney David; Chin Bernard S P; Lip Gregory Y H
Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.
Stroke; a journal of cerebral circulation 2002;33(5):1237-42.
2002: Marwah S S; Blann A; Harrison P; Lumley M A; Wright J; McDowell J; Phillips J D; Rea C; Bareford D
Increased non-transferrin bound iron in plasma-depleted SAG-M red blood cell units.
Vox sanguinis 2002;82(3):122-6.
2002: Blann Andrew D; Lip Gregory Y H
Soluble adhesion molecules and coronary heart disease.
Lancet 2002;359(9305):525-6; author reply 526-7.
2002: Marwah S S; Blann A D; Rea C; Phillips J D; Wright J; Bareford D
Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis.
American journal of hematology 2002;69(2):144-6.
2002: Blann A D; Nitu-Whalley I C; Lee C A; Lip G Y H
Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease.
American journal of hematology 2002;69(2):135-7.
2002: Blann Andrew D; Belgore Funmi M; McCollum Charles N; Silverman Stanley; Lip Peck Lin; Lip Gregory Y H
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
Clinical science (London, England : 1979) 2002;102(2):187-94.
2002: Lip G Y H; Blann A D; Edmunds E; Beevers D G
Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(1):35-41.
2002: Lip Gregory Y H; Chin Bernard S P; Blann Andrew D
Cancer and the prothrombotic state.
The lancet oncology 2002;3(1):27-34.
2001: Kamath S; Blann A D; Lip G Y
Platelets and atrial fibrillation.
European heart journal 2001;22(24):2233-42.
2001: Gibbs C R; Blann A D; Edmunds E; Watson R D; Lip G Y
Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
Clinical cardiology 2001;24(11):724-9.
2001: Blann A D; Lanza F; Galajda P; Gurney D; Moog S; Cazenave J P; Lip G Y
Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smoking.
Thrombosis and haemostasis 2001;86(3):777-83.
2001: Marwah S S; Wheelwright D; Blann A D; Rea C; Beresford R; Phillips J D; Wright J; Bareford D
Vitamin E correlates inversely with non-transferrin-bound iron in sickle cell disease.
British journal of haematology 2001;114(4):917-9.
2001: Blann A D; Adams R; Ashleigh R; Naser S; Kirkpatrick U; McCollum C N
Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease.
The British journal of radiology 2001;74(885):811-7.
2001: Li-Saw-Hee F L; Blann A D; Gurney D; Lip G Y
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
European heart journal 2001;22(18):1741-7.
2001: Kamath S; Blann A D; Lip G Y
Platelet activation: assessment and quantification.
European heart journal 2001;22(17):1561-71.
2001: Lip G Y; Edmunds E; Hee F L; Blann A D; Beevers D G
A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
American journal of hypertension 2001;14(8 Pt 1):823-8.
2001: Lip G Y; Edmunds E; Martin S C; Jones A F; Blann A D; Beevers D G
A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage.
American journal of hypertension 2001;14(7 Pt 1):627-31.
2001: Blann A D; Gurney D; Hughes E; Buggins P; Silverman S H; Lip G Y
Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease.
The American journal of cardiology 2001;88(1):A7-8, 89-92.
2001: Lip G Y; Blann A D; Farooqi I S; Zarifis J; Sagar G; Beevers D G
Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(4):307-15.
2001: Blann A D; Belgore F M; Constans J; Conri C; Lip G Y
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate.
The American journal of cardiology 2001;87(10):1160-3.
2001: Li-Saw-Hee F L; Blann A D; Edmunds E; Gibbs C R; Lip G Y
Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Clinical cardiology 2001;24(5):409-14.
2001: Belgore F M; Blann A D; Lip G Y
Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
Clinical science (London, England : 1979) 2001;100(5):567-75.
2001: Lip P L; Blann A D; Hope-Ross M; Gibson J M; Lip G Y
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
Ophthalmology 2001;108(4):705-10.
2001: Gibbs C R; Blann A D; Watson R D; Lip G Y
Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Circulation 2001;103(13):1746-51.
2001: Belgore F M; Blann A D; Li-Saw-Hee F L; Beevers D G; Lip G Y
Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension.
The American journal of cardiology 2001;87(6):805-7, A9.
2001: Belgore F M; Lip G Y; Bareford D; Wadley M; Stonelake P; Blann A D
Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
American journal of hematology 2001;66(1):59-61.
2001: Blann A D; Gurney D; Wadley M; Bareford D; Stonelake P; Lip G Y
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(1):43-50.
2001: Goldsmith I R; Blann A D; Patel R L; Lip G Y
Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
The American journal of cardiology 2001;87(1):107-10, A9.
2001: Blann A D; Amiral J; Taberner D A
Platelet and endothelial-cell markers in meningococcal septicaemia: a report of two cases.
British journal of biomedical science 2001;58(1):37-40.
2000: Braybrooke J P; O'Byrne K J; Propper D J; Blann A; Saunders M; Dobbs N; Han C; Woodhull J; Mitchell K; Crew J; Smith K; Stephens R; Ganesan T S; Talbot D C; Harris A L
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4697-704.
2000: Goldsmith I; Kumar P; Carter P; Blann A D; Patel R L; Lip G Y
Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.
American heart journal 2000;140(5):777-84.
2000: Lip G Y; Lydakis C; Nuttall S L; Landray M J; Watson R D; Blann A D
A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Journal of internal medicine 2000;248(4):316-8.
2000: Blann A D
Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(7):623-30.
2000: Li-Saw-Hee F L; Blann A D; Lip G Y
Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation.
The American journal of cardiology 2000;86(7):795-7, A9.
2000: Blann A D; Amiral J; McCollum C N; Lip G Y
Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls.
Atherosclerosis 2000;152(1):29-34.
2000: Constans J; Seigneur M; Blann A D; Lestage B; Resplandy F; Renard M; Chaudet B; Amiral J; Guérin V; Boisseau M R; Conri C
Endothelial function, platelet activation and coagulation in lower limb occlusive arterial disease during treadmill exercise: correlations with transcutaneous oxygen pressure.
Thrombosis research 2000;99(6):557-61.
2000: Li-Saw-Hee F L; Edmunds E; Blann A D; Beevers D G; Lip G Y
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
International journal of cardiology 2000;75(1):43-7.
2000: Belgore F M; Lip G Y; Bareford D; Blann A D
Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers.
British journal of haematology 2000;110(2):496-7.
2000: Goldsmith I R; Foo L S; Blann A D; Lip G Y
Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
Clinical cardiology 2000;23(8):587-90.
2000: Goldsmith I R; Blann A D; Patel R L; Lip G Y
Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation.
The American journal of cardiology 2000;86(2):234-6.
2000: Lip P L; Belgore F; Blann A D; Hope-Ross M W; Gibson J M; Lip G Y
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Investigative ophthalmology & visual science 2000;41(8):2115-9.
2000: Li-Saw-Hee F L; Blann A D; Lip G Y
A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
Journal of the American College of Cardiology 2000;35(7):1926-31.
2000: Goldsmith I R; Blann A D; Patel R L; Lip G Y
von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
The American journal of cardiology 2000;85(10):1218-22.
2000: Goldsmith I R; Blann A D; Patel R L; Lip G Y
Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction.
Heart (British Cardiac Society) 2000;83(5):577-8.
2000: Li-Saw-Hee F L; Blann A D; Lip G Y
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Stroke; a journal of cerebral circulation 2000;31(4):828-33.
2000: Blann A D; Farrell A; Picton A; McCollum C N
Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease.
Thrombosis research 2000;97(4):209-16.
2000: Constans J; Blann A D; Renard M; Guérin V; Conri C
Soluble thrombomodulin in hypercholesterolaemic patients.
Lancet 2000;355(9198):145.
2000: Blann A D; Noteboom W M; Rosendaal F R
Increased soluble P-selectin levels following deep venous thrombosis: cause or effect?
British journal of haematology 2000;108(1):191-3.
2000: Kirkpatrick U J; Blann A D; Adams R A; McCollum C N
Soluble adhesion molecules in clinical ischaemic injury.
International journal of surgical investigation 2000;2(2):151-8.
2000: Belgore F M; Lip G Y; Blann A D
Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
British journal of biomedical science 2000;57(3):207-13.
1999: Constans J; Blann A D; Resplandy F; Parrot F; Renard M; Seigneur M; Guérin V; Boisseau M; Conri C
Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction.
British journal of haematology 1999;107(4):776-8.
1999: Constans J; Blann A D; Resplandy F; Parrot F; Seigneur M; Renard M; Amiral J; Guérin V; Boisseau M R; Conri C
Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients.
Atherosclerosis 1999;147(2):411-3.
1999: Blann A; Hewitt J; Siddiqui F; Bareford D
Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.
British journal of haematology 1999;107(1):207-9.
1999: Lip G Y; Blann A D; Beevers D G
Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension.
Journal of hypertension 1999;17(8):1203-7.
1999: Blann A; Kumar P; Krupinski J; McCollum C; Beevers D G; Lip G Y
Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(5):277-84.
1999: Li-Saw-Hee F L; Blann A D; Goldsmith I; Lip G Y
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
The American journal of cardiology 1999;83(8):1206-9.
1999: Jilma B; Blann A; Pernerstorfer T; Stohlawetz P; Eichler H G; Vondrovec B; Amiral J; Richter V; Wagner O F
Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin.
American journal of respiratory and critical care medicine 1999;159(3):857-63.
1999: Kirkpatrick U J; Burrows G; Blann A; McCollum C N
Neutrophil activation and severity of tissue hypoxia during tourniquet-induced forearm ischemia in man.
Experimental and molecular pathology 1999;65(3):111-20.
1998: Constans J; Seigneur M; Blann A D; Renard M; Resplandy F; Amiral J; Guérin V; Boisseau M R; Conri C
Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction.
Thrombosis and haemostasis 1998;80(6):1015-7.
1998: Blann A D; Kirkpatrick U; Devine C; Naser S; McCollum C N
The influence of acute smoking on leucocytes, platelets and the endothelium.
Atherosclerosis 1998;141(1):133-9.
1998: Blann A; Bignell A; McCollum C
von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity.
Atherosclerosis 1998;139(2):317-22.
1998: Blann A D; Lip G Y
Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(8):634-42.
1998: Blann A D
Adhesion molecules in cardiovascular disease: Opportunities for new therapeutic directions?
IDrugs : the investigational drugs journal 1998;1(3):315-20.
1998: Blann A D; Lip G Y
The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(4):297-306.
1998: Blann A D; Seigneur M; Steiner M; Miller J P; McCollum C N
Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events.
Thrombosis and haemostasis 1998;79(6):1080-5.
1998: Constans J; Guérin V; Couchouron A; Seigneur M; Ryman A; Blann A D; Amiral J; Amara A; Peuchant E; Moreau J F; Pellegrin I; Pellegrin J L; Fleury H; Leng B; Conri C
Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies.
European journal of clinical investigation 1998;28(2):115-22.
1998: Lip P L; Blann A D; Jones A F; Lip G Y
Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Eye (London, England) 1998;12 ( Pt 2)():245-51.
1997: Blann A D; Lip G Y
Platelets and hypertension: the pressure is on the clot.
Journal of human hypertension 1997;11(12):763-4.
1997: Lip G Y; Blann A D; Jones A F; Lip P L; Beevers D G
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
The American journal of cardiology 1997;80(12):1566-71.
1997: Kirkpatrick U J; Mossa M; Blann A D; McCollum C N
Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication.
Thrombosis and haemostasis 1997;78(5):1338-42.
1997: Blann A D; Seigneur M; Steiner M; Boisseau M R; McCollum C N
Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease.
European journal of clinical investigation 1997;27(11):916-21.
1997: Blann A D; Faragher E B; McCollum C N
Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(7):383-90.
1997: Lip G Y; Blann A D; Jones A F; Beevers D G
Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis.
American heart journal 1997;134(4):764-71.
1997: Li-Saw-Hee F L; Blann A D; Lip G Y
The detection of endothelial dysfunction in patients with essential hypertension.
International journal of cardiology 1997;61(2):171-4.
1997: Blann A D; Miller J P; McCollum C N
von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia.
Atherosclerosis 1997;132(2):151-6.
1997: Blann A D; Lip G Y; Beevers D G; McCollum C N
Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Thrombosis and haemostasis 1997;77(6):1077-80.
1997: Lip G Y; Blann A
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?
Cardiovascular research 1997;34(2):255-65.
1997: Seigneur M; Constans J; Blann A; Renard M; Pellegrin J L; Amiral J; Boisseau M; Conri C
Soluble adhesion molecules and endothelial cell damage in HIV infected patients.
Thrombosis and haemostasis 1997;77(4):646-9.
1997: Blann A D; Sheeran T P; Emery P
von Willebrand factor: increased levels are related to poor prognosis in systemic sclerosis and not to tissue autoantibodies.
British journal of biomedical science 1997;54(1):5-9.
1997: Blann A D; Steele C; McCollum C N
The influence of smoking on soluble adhesion molecules and endothelial cell markers.
Thrombosis research 1997;85(5):433-8.
1997: Blann A D; Lip G Y
Hypothesis: is soluble P-selectin a new marker of platelet activation?
Atherosclerosis 1997;128(2):135-8.
1997: Blann A; Seigneur M
Soluble markers of endothelial cell function.
Clinical hemorheology and microcirculation 1997;17(1):3-11.
1996: Blann A D; Seigneur M; Boisseau M R; Taberner D A; McCollum C N
Soluble P selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factors.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(8):789-93.
1996: Richard S; Seigneur M; Blann A; Adams R; Renard M; Puntous M; Boiron J M; Amiral J; Reiffers J; Boisseau M
Vascular endothelial lesion in patients undergoing bone marrow transplantation.
Bone marrow transplantation 1996;18(5):955-9.
1996: Blann A D; Amiral J; McCollum C N
Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease.
British journal of haematology 1996;95(2):263-5.
1996: Blann A; Morris J; McCollum C
Soluble L-selectin in peripheral arterial disease: relationship with soluble E-selectin and soluble P-selectin.
Atherosclerosis 1996;126(2):227-31.
1996: Blann A D; Sanders P A; Herrick A; Jayson M I
Soluble L-selectin in the connective tissue diseases.
British journal of haematology 1996;95(1):192-4.
1996: Daly R J; Blann A D
Self-reported smoking in vascular disease: the need for biochemical confirmation.
British journal of biomedical science 1996;53(3):204-8.
1996: Blann A D; Seigneur M; Adams R A; McCollum C N
Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 1996;12(2):218-22.
1996: Blann A D; Adams R A; Katai F; Ashleigh R; Taberner D A
Haematology and coagulation indices in paired samples of arterial and venous blood from patients with arterial disease.
Haemostasis 1996;26(2):72-8.
1996: Blann A D; Waite M A
von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis.
Coronary artery disease 1996;7(2):143-7.
1996: Blann A D; Wang J M; Wilson P B; Kumar S
Serum levels of the TGF-beta receptor are increased in atherosclerosis.
Atherosclerosis 1996;120(1-2):221-6.
1996: Blann A D; Daly R J; Amiral J
The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules.
British journal of haematology 1996;92(2):498-500.
1995: Lip G Y; Blann A D; Zarifis J; Beevers M; Lip P L; Beevers D G
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Journal of hypertension 1995;13(12 Pt 2):1674-8.
1995: Blann A D; Herrick A; Jayson M I
Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis.
British journal of rheumatology 1995;34(9):814-9.
1995: Blann A D; Dobrotova M; Kubisz P; McCollum C N
von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Thrombosis and haemostasis 1995;74(2):626-30.
1995: Blann A D; Maxwell S R; Burrows G; Miller J P
Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease.
Atherosclerosis 1995;116(2):191-8.
1995: Blann A D; Taberner D A
A reliable marker of endothelial cell dysfunction: does it exist?
British journal of haematology 1995;90(2):244-8.
1995: Blann A D; Mather H; Miller J P; McCollum C N
Atherosclerosis risk factors: variation in healthy hospital workers and members of local communities asymptomatic for vascular disease. Implications for normal controls.
British journal of biomedical science 1995;52(1):31-4.
1994: Blann A D; Tse W; Maxwell S J; Waite M A
Increased levels of the soluble adhesion molecule E-selectin in essential hypertension.
Journal of hypertension 1994;12(8):925-8.
1994: Blann A D; McCollum C N
Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis.
Thrombosis and haemostasis 1994;72(1):151-4.
1993: Blann A D; Bushell D; Davies A; Faragher E B; Miller J P; McCollum C N
von Willebrand factor, the endothelium and obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1993;17(12):723-5.
1993: Blann A; Midgley H; Burrows G; Maxwell S; Utting S; Davies M; Waite M; McCollum C
Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplasty.
Coronary artery disease 1993;4(10):905-10.
1993: Blann A
von Willebrand factor and the endothelium in vascular disease.
British journal of biomedical science 1993;50(2):125-34.
1993: Blann A D; Naqvi T; Waite M; McCollum C N
von Willebrand factor and endothelial damage in essential hypertension.
Journal of human hypertension 1993;7(2):107-11.
1993: Blann A D; Midgley H S; Burrows G; Maxwell S; Utting S; Waite M A
Oxygen free radicals, reperfusion injury, endothelial cells, and von Willebrand factor.
Cardiovascular research 1993;27(1):141-2.
1991: Blann A D
von Willebrand factor antigen as an acute phase reactant and marker of endothelial cell injury in connective tissue diseases: a comparison with CRP, rheumatoid factor, and erythrocyte sedimentation rate.
Zeitschrift für Rheumatologie 1991;50(5):320-2.

Sign-in to see more